Berylson Capital Partners’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-265,000
Closed -$2.78M 32
2021
Q2
$2.78M Hold
265,000
0.62% 48
2021
Q1
$2.73M Hold
265,000
0.66% 40
2020
Q4
$2.94M Buy
+265,000
New +$2.7M 0.5% 57

Other funds holding SRTA

Berylson Capital Partners's SRTA Position: Q3 2021 in Review

Berylson Capital Partners sold out of Strata Critical Medical Inc (SRTA) in Q3 2021, closing a stake of 265,000 shares — an estimated $2.78M sold.

Berylson Capital Partners first reported a position in SRTA in Q4 2020 and held it in 3 quarters. The position peaked at $2.94M in Q4 2020. 81 funds tracked by Wall St. Rank hold SRTA as of Q3 2021.

  • Berylson Capital Partners reported no remaining Strata Critical Medical Inc position as of Q3 2021 after selling out during the quarter.
  • Berylson Capital Partners sold 265,000 Strata Critical Medical Inc shares in Q3 2021, an estimated $2.78M.
  • Berylson Capital Partners first reported a position in Strata Critical Medical Inc in Q4 2020 and held it in 3 quarters.
  • Berylson Capital Partners's Strata Critical Medical Inc position peaked at $2.94M in Q4 2020.
  • 81 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q3 2021.

Based on Berylson Capital Partners's 13F filing for Q3 2021, filed 15 Nov 2021.